It is found that YY1 transcriptionally upregulates IL‐32 secretion in pericytes, which binds to and activates β5‐integrin in cancer cells, triggering the Src‐Akt signaling pathway and reducing TKI sensitivity. Here, YY1 is linked to cancer.